Product Datasheet
Methionine Aminopeptidase 2 Antibody
Catalog Number: 49961
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:P50579
- Form of Antibody:
- 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
- Immunogen:
- Recombinant protein within C-terminal human Methionine Aminopeptidase 2.
- appl_detail:
- WB: 1:500-1:2,000
IHC: 1:50-1:200
ICC/IF: 1:50-1:200
FC: 1:50-1:100
- other_names:
- A930035J23Rik antibody
AI047573 antibody
AL024412 antibody
Amp2 antibody
AU014659, antibody
EIF 2 associated p67 homolog antibody
EIF-2-associated p67 antibody
Initiation factor 2 associated 67 kDa glyco
- Purification:
- ProA affinity purified
- Applications:
- WB,ICC,IF,IHC,FC
- Background:
- Methionine aminopeptidases (MetAP), also designated peptidase M proteins, are members of the M24 family of proteins. Both MetAP-1 and MetAP-2 release N-terminal amino acids, usually methionine, from nascent peptides and arylamines. Eukaryotes contain both MetAP-1 and MetAP-2, whereas prokaryotes possess only the MetAP-1 enzyme. MetAP-1 and MetAP-2 control cell proliferation in mammalian cells. MetAP-2 is highly conserved between human and Saccharomyces cerevisiae. Neurofibromin (NF1) regulates MetAp-2 and increased expression of MetAP-2 correlates with several forms of cancer. Inhibitors of MetAP-2 are potential targets in cancer therapeutics, particularly in NF1-associated tumor proliferation. Chemotherapeutic drugs such as ovalicin and fumagillin bind to the active site of and inhibit MetAp-2.
© Signalway Biotechnology All Rights Reserved.